IRIS
FALOPPI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.957
EU - Europa 1.016
AS - Asia 440
SA - Sud America 122
AF - Africa 62
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.600
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.955
IT - Italia 203
UA - Ucraina 194
SG - Singapore 138
SE - Svezia 122
BR - Brasile 112
IE - Irlanda 108
RU - Federazione Russa 104
TR - Turchia 104
DE - Germania 92
CN - Cina 86
DK - Danimarca 76
FI - Finlandia 65
HK - Hong Kong 55
KR - Corea 41
CI - Costa d'Avorio 34
GB - Regno Unito 26
MA - Marocco 21
FR - Francia 14
IN - India 9
DZ - Algeria 6
NL - Olanda 6
VE - Venezuela 4
BD - Bangladesh 3
EU - Europa 3
BE - Belgio 2
CO - Colombia 2
EC - Ecuador 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
BG - Bulgaria 1
CL - Cile 1
CZ - Repubblica Ceca 1
IQ - Iraq 1
JM - Giamaica 1
KG - Kirghizistan 1
MX - Messico 1
RS - Serbia 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 3.600
Salva come PNG Salva come JPEG
Città #
Chandler 253
Fairfield 219
Jacksonville 210
Ashburn 128
Wilmington 124
Dublin 108
Boardman 100
Seattle 89
Woodbridge 89
Centro 73
Houston 69
New York 69
Cambridge 66
Singapore 63
Ann Arbor 61
Hong Kong 55
Des Moines 53
Lawrence 44
Princeton 44
San Mateo 44
Turin 35
Abidjan 33
Moscow 23
Helsinki 22
The Dalles 18
Beijing 16
San Diego 16
London 9
Pune 9
Wuxi 8
Izmir 7
Los Angeles 6
Washington 6
Norwalk 5
Shanghai 5
São Paulo 5
Belo Horizonte 4
Fayetteville 4
Kilburn 4
Rio de Janeiro 4
Turku 4
Wuhan 4
Ancona 3
Brasília 3
Curitiba 3
Dallas 3
Duque de Caxias 3
Guangzhou 3
Milan 3
Munich 3
New Bedfont 3
Portland 3
Prescot 3
Amsterdam 2
Bogotá 2
Bom Despacho 2
Brussels 2
Campinas 2
Chicago 2
Chiswick 2
Como 2
Council Bluffs 2
Dalian 2
Florence 2
Fortaleza 2
Isola della Scala 2
Itaquaquecetuba 2
Jinhua 2
Modena 2
Montesilvano 2
Piracicaba 2
Ribeirão Preto 2
Roseto degli Abruzzi 2
San Francisco 2
Venice 2
Yiwu 2
Acton 1
Alcobaça 1
Anta Gorda 1
Antalya 1
Aparecida 1
Arcoverde 1
Armação dos Búzios 1
Ascoli Piceno 1
Bagé 1
Basra 1
Belgrade 1
Betim 1
Bishkek 1
Bordj el Kiffan 1
Cachoeira 1
Cachoeira do Sul 1
Caracas 1
Carapicuíba 1
Caratinga 1
Carmo da Cachoeira 1
Carutapera 1
Catanduvas 1
Caxias do Sul 1
Caçapava 1
Totale 2.311
Salva come PNG Salva come JPEG
Nome #
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 140
The role of Aspirin as antitumoral agent for heavily pre-treated metastatic colorectal cancer patients receiving capecitabine monotherapy. BMC Cancer 137
Immunotherapy in genitourinary cancers: Where are we going? 137
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 125
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 116
The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment 102
Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management 101
Clinical evidence for three distinct gastric cancer subtypes: time for a new approach. 96
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab. 94
CANCER STEM CELL GENETIC PROFILE AS PREDICTOR OF RELAPSE IN RADICALLY RESECTED COLORECTAL CANCER 94
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study 93
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 91
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study 90
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. 88
Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation. 88
Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab 87
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab. 87
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients. 86
Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter 85
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. 83
The "angiogenetic ladder", step-wise angiogenesis inhibition in metastatic colorectal cancer 83
Beyond RAS: the role of epidermal growth factor receptor (EGFR) and its network in the prediction of clinical outcome during anti-EGFR treatment in colorectal cancer patients 83
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management 83
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New 79
Prognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer 78
The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following? 76
Panitumumab for the treatment of metastatic colorectal cancer: A review 76
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma 75
Trattamento del carcinoma del pancreas. Attualità e prospettive 74
Targeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studies 73
The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for advanced renal cell carcinoma patients receiving first-line sunitinib 72
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients. 70
Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients. 70
Toward molecularly selected chemotherapy for advanced gastric cancer: state of the art and future perspectives. 69
Gastric cancer: Therapeutic choices in advanced disease 69
Selecting the best treatment for an individual patient. 66
Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis 65
Selected gastrointestinal cancer presentations from the American Society of Clinical Oncology annual meeting 2013 in review: It is not about the destination, it is about the journey 64
The Tower of Babel of liver metastases from colorectal cancer: Are we ready for one language? 60
Tracking the 2015 gastrointestinal cancers symposium: Bridging cancer biology to clinical gastrointestinal oncology 60
Palliative treatment 59
Selected news from the 2014 Genitourinary Cancers Symposium: Translating novel strategies into clinical practice 57
Cetuximab: still an option in the treatment of pancreatic cancer? Expert Opin Biol Ther. 2013 May;13(5):791-801 55
Predictive factors for sunitinib treatment response in advanced renal cell carcinoma: are we really making steps forward? 53
Totale 3.689
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.036
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.036
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202077 0 0 0 0 0 0 0 0 0 0 16 61
2020/2021784 47 78 79 4 135 67 73 52 57 92 67 33
2021/2022357 28 82 7 6 2 23 15 24 20 54 26 70
2022/2023745 51 105 58 55 47 119 1 44 168 3 78 16
2023/2024388 59 4 39 50 60 104 6 4 1 6 7 48
2024/2025631 112 71 12 11 49 29 102 31 141 58 15 0
Totale 3.689